Our Solution

Meet Our Technology

Our core technology transforms the timeline of acute diagnostic testing by combining three breakthrough systems into one seamless workflow. Starting with a raw whole blood sample, our patented centrifugal disk isolates pathogens in just four minutes. Following further filtering and microfluidic processing, we utilize Raman spectroscopy and advanced AI for rapid pathogen identification.

————
Centrifugal Pathogen Isolation

Single-use centrifugal disk isolates pathogens from whole blood within four minutes

————
Raman Spectroscopy & AI ID

Raman spectroscopy and AI/ML analysis enables rapid pathogen identification

How It Works

Rapid Centrifugal Isolation

Our patented sample preparation technology bypasses the traditional blood culture bottleneck entirely. Utilizing custom fluid dynamics and targeted sedimentation forces within a single-use disk, the system rapidly extracts and isolates intact pathogens directly from a raw whole blood sample in just four minutes, preparing it for immediate downstream analysis.

Raman Spectroscopy & Advanced AI -- Under Development

Step 1

Load the whole blood sample directly into the disk.

services image

Step 2

Spin the sample up to 3,000 RPM for 20 seconds

services image

Step 3

Separate target pathogens from background interferents via sedimentation forces.

services image

Step 4

Decelerate precisely for four minutes to isolate plasma

services image
Rapid Sepsis Pathogen ID

How do we compare? 2

References -->
Diagnostic Ventures
icon

Within 20 Minutes

icon

$50,000 Instrument Cost

icon

Unlimited Bacterial Spectrum Unlimited Resistance Genes

GenMark Diagnostics (Roche)
icon

17.5 hours including PBC

icon

$165,000  Instrument Cost

icon

46 Bacterial Targets
10 Resistance Genes

BioMerieux
icon

16 hours including PBC

icon

$62,000  Instrument Cost

icon

26 Bacterial Targets
10 Resistance Genes

Track Our Progress

Join us as we redefine the timeline of acute diagnostic testing, working bring the world’s fastest sepsis pathogen ID platform to market.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CTA Image
1. Kumar A, et al. Crit Care Med2006;34:1589-1596 7.6% increase of mortality

2. Competitive Reports